Skip to main content
Premium Trial:

Request an Annual Quote

Vanderbilt Researchers to Use Waters' Synapt in Oncology Studies

NEW YORK (GenomeWeb News) – Waters announced today that researchers at Vanderbilt University will use the firm’s Synapt HDMS system to enhance their tissue imaging capabilities in oncology studies being conducted at the school’s Mass Spectrometry Research Center.
Researchers at the center are using mass spec technologies to identify and visualize protein expression changes in cells through various stages of cancer.
“Ultimately, we hope that enhanced tissue imaging techniques will provide data sets to be mined for diagnostic and prognostic information related to the various stages of cancer,” Richard Caprioli, director of Vanderbilt’s MSRC, said in a statement.
Waters introduced the Synapt HDMS at the annual American Society of Mass Spectrometry meeting in June 2006. The platform incorporates high efficiency ion mobility separation in a dual ionization mass spectrometer. Over the past few quarters company officials have cited the instrument as a key revenue growth driver.

The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.